Skip to content

Author

A. Maikenova

We have 1 of 4 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access 2026

The Use of Selpercatinib in Recurrent Medullary Thyroid Carcinoma with the RET p.C630R Mutation: A Clinical Case

Medullary thyroid carcinoma (MTC) is a rare malignant tumor arising from parafollicular C cells and accounts for 1–5% of all thyroid cancers. Somatic RET mutations occur in 40–50% of sporadic cases and represent targets for selective RET inhibitors. Selpercatinib (RETEVMO, Eli Lilly), approved by the FDA in 2020 and th...

M. Mauletbayev, A. Maikenova, B. Yermekbaeva · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.